Titan Biotech (BOM:524717) EPS (Basic): ₹7.23 (TTM As of Mar. 2026)


BOM:524717 Titan Biotech Ltd BOM:524717
50 GF Score
Price ₹397.05
GF Value ₹143.96
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Titan Biotech EPS (Basic)?

Titan Biotech BOM:524717 -3.87% 50 EPS (Basic) is ₹7.23 as of Mar. 2026. GuruFocus rates BOM:524717 with a GF Score™ of 50/100 and a GF Value™ of ₹143.96 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Titan Biotech's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹1.63. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹7.23.

Titan Biotech's EPS (Diluted) for the three months ended in Mar. 2026 was ₹1.63. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹7.23.

Titan Biotech's EPS without NRI for the three months ended in Mar. 2026 was ₹1.63. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 7.23.

During the past 12 months, Titan Biotech's average EPS without NRIGrowth Rate was 38.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 6.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -0.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 36.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Titan Biotech's highest 3-Year average EPS without NRI Growth Rate was 124.70% per year. The lowest was -7.50% per year. And the median was 10.25% per year.

Titan Biotech  (BOM:524717) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Titan Biotech EPS (Basic) Related Terms

Titan Biotech EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Titan Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Titan Biotech EPS (Basic) Chart

Titan Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.25 6.01 6.01 5.21 7.23

Titan Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.66 1.88 2.06 1.63
BOM:524717
50GF Score
Titan Biotech Ltd BOM:524717
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Titan Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Titan Biotech's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(298.852-0)/41.335
=7.23

Titan Biotech's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(67.291-0)/41.283
=1.63

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹7.23 mean?
Titan Biotech (BOM:524717) has a EPS (Basic) of ₹7.23 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Titan Biotech and its competitors.
Is Titan Biotech's EPS (Basic) too high?
Titan Biotech's current EPS (Basic) is ₹7.23. Overall, Titan Biotech has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Titan Biotech's EPS (Basic) compare to VRTX and REGN?
Titan Biotech's EPS (Basic) of ₹7.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Titan Biotech and its competitors. Titan Biotech's current EPS (Basic) is ₹7.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Titan Biotech stock overvalued right now?
Based on GuruFocus' analysis, Titan Biotech (BOM:524717) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹143.96, compared to a current price of ₹397.05 — trading 175.8% above its estimated fair value. The current EPS (Basic) is ₹7.23. Titan Biotech's overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Titan Biotech (BOM:524717), the current EPS (Basic) is ₹7.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Titan Biotech (BOM:524717) Overvalued in 2026?

Based on GuruFocus' analysis, Titan Biotech stock appears to be overvalued. The current stock price of ₹397.05 is trading 175.8% above its estimated GF Value™ of ₹143.96. GuruFocus considers Titan Biotech to be Significantly Overvalued.

Key valuation signals for BOM:524717:

  • EPS (Basic): ₹7.23
  • GF Value™: ₹143.96 vs. price of ₹397.05 (175.8% above fair value)
  • GF Score™: 50/100 with 2 warning signs

No single metric tells the full story. See the BOM:524717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Titan Biotech Business Description

Address Netaji Subhash Place, 903-909, 9th Floor, Bigjos Tower, New Delhi, IND, 110034
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters, and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The company's business activity falls within a single primary business segment, which is the business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.
50GF Score

Get the complete analysis for BOM:524717

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹397.05
Price
₹143.96
GF Value